Robert Martin Emanuele's Net Worth
$1.32 Million
Who is Robert Martin Emanuele?
Robert Martin Emanuele has an estimated net worth of $1.32 Million. This is based on reported shares across multiple companies, which include ARTELO BIOSCIENCES, INC., ADVENTRX PHARMACEUTICALS INC, and AVANIR PHARMACEUTICALS.
SEC CIK
Robert Martin Emanuele's CIK is 0001184991
Past Insider Trading and Trends
2024 was Robert Martin Emanuele's most active year for acquiring shares with 7 total transactions. Robert Martin Emanuele's most active month to acquire stocks was the month of January. 2024 was Robert Martin Emanuele's most active year for disposing of shares, totalling 7 transactions. Robert Martin Emanuele's most active month to dispose stocks was the month of January. 2006 saw Robert Martin Emanuele paying a total of $8,990.00 for 1,000 shares, this is the most they've acquired in one year. In 2011 Robert Martin Emanuele cashed out on 41,000 shares for a total of $24,431.90, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARTELO BIOSCIENCES, INC. (ARTL) Snapshot price: $1.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ADVENTRX PHARMACEUTICALS INC (SVRA) Snapshot price: $4.42
Senior VP, Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +21.71% | 52.54K |
—
|
—
| 294.6K |
May 30
| |||
Form 4
| -55.80% | -305.61K |
—
| -$305.61 | 242.06K |
Dec 13
| |||
Form 4
| -6.96% | -41.00K |
$0.60 | -$24,431.90 | 547.66K |
Scheduled
|
Dec 16
| ||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVANIR PHARMACEUTICALS No price found
V P, Business Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1K |
$8.99 | $8,990.00 | 1K |
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
| No matching records found | |||||||||